Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Feng Gao

Associate Professor

Washington University in St. Louis

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Pharmacotherapy

90%

Immunology

30%

Targeted Therapy

50%

Oncology

40%

Graft-versus-host Disease

30%

Hematology

30%

Neoadjuvant Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles12

Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids

Article Link

Year:

2024

Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial

Article Link

Year:

2023

Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality

Article Link

Year:

2022

Statistical estimation and comparison of group-specific bivariate correlation coefficients in family-type clustered studies

Article Link

Year:

2022

Evaluating chronotypically tailored light therapy for breast cancer survivors: Preliminary findings on fatigue and disrupted sleep

Article Link

Year:

2022

A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma

Article Link

Year:

2021

Machine learning-based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors.

Article Link

Year:

2021

Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors.

Article Link

Year:

2021

Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies

Article Link

Year:

2021

Survival after autologous versus allogeneic transplantation in patients with relapsed and refractory Hodgkin lymphoma

Article Link

Year:

2021

Baricitinib prevents GvHD by increasing Tregs via JAK3 and treats established GvHD by promoting intestinal tissue repair via EGFR

Article Link

Year:

2021

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer.

Article Link

Year:

2021

Collaborators9

Geoffrey Uy

Professor of Medicine

Washington University School of Medicine

UNITED STATES

Keith Stockerl-Goldstein

Professor of Medicine

Washington University in St. Louis

UNITED STATES

Ramzi Abboud

Washington University School of Medicine

UNITED STATES

Foluso O. Ademuyiwa

UNITED STATES

Akhil Srivastava

University of Missouri School of Medicine

UNITED STATES

Mark Fiala

Assistant Professor

Washington University School of Medicine

UNITED STATES

Shamim Mollah

Assistant Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

Michael Slade

Assistant Professor

Washington University in St. Louis

UNITED STATES

Jaebok Choi

Assistant Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

How do I reach out?

Meet Kite AI